40 Works
How Shareholders Impact Stakeholder Interests: A Review and Map for Future Research
Mark R. DesJardine, Muhan Zhang & Wei Shi
Research on how shareholders influence the interests of stakeholders has proliferated in recent years, at pace with the active debate on the merits of “stakeholder capitalism.” This research has sought to unpack: (1) the types of shareholders that affect stakeholder-relevant firm outcomes, (2) the mechanisms through which shareholders exert their influence on stakeholders’ interests, (3) the types of stakeholders that are influenced by shareholders, and (4) the factors that moderate the influence of shareholders on...
Additional file 1 of Two decades of FDG-PET/CT in seminoma: exploring its role in diagnosis, surveillance and follow-up
Ciara Conduit, Thuan Tzen Koh, Michael S Hofman, Guy C Toner, Jeremy Goad, Nathan Lawrentschuk, Keen-Hun Tai, Jeremy H Lewin & Ben Tran
Supplementary table 1
Additional file 5 of JAK1 inactivation promotes proliferation and migration of endometrial cancer cells via upregulating the hypoxia-inducible factor signaling pathway
Qin Lin, Zheng Chen, Wei Shi, Zeheng Lv, Xiaoping Wan & Kun Gao
Additional file 5. Supplementary Tables.
Additional file 3 of Ganciclovir-induced mutations are present in a diverse spectrum of post-transplant malignancies
Hu Fang, Helen H. N. Yan, Rebecca A. Bilardi, Christoffer Flensburg, Haocheng Yang, Jayne A. Barbour, Hoi Cheong Siu, Michelle Turski, Edward Chew, Zhen Xu, Siu T. Lam, Rakesh Sharma, Mengya Xu, Junshi Li, Ho W. Ip, Carol Y. M. Cheung, Michael S. Y. Huen, E. Alejandro Sweet-Cordero, Ian J. Majewski, Suet Y. Leung & Jason W. H. Wong
Additional file 3: Figure S1. Determination of sensitivity and false discovery rate based on SBS18 and SBS38. Figure S2. Trinucleotide mutational spectra of the additional 21 samples with GCVsig detected from AACR Project GENIE and Foundation Medicine cohorts. Figure S3. Permutation test to determine cohort-wide false discovery rate. Figure S4. Replication strand bias for cell lines and cancer samples. Figure S5. Mutation burden of GCV positive samples relative to other samples by cancer type. Figure...
Two decades of FDG-PET/CT in seminoma: exploring its role in diagnosis, surveillance and follow-up
Ciara Conduit, Thuan Tzen Koh, Michael S Hofman, Guy C Toner, Jeremy Goad, Nathan Lawrentschuk, Keen-Hun Tai, Jeremy H Lewin & Ben Tran
Abstract Background Survivors of testicular cancer may experience long-term morbidity following treatment. There is an unmet need to investigate techniques that can differentiate individuals who need additional therapy from those who do not. 2-18fluoro-deoxy-D-glucose (FDG) positron emission tomography (PET) with computerised tomography (CT) may be helpful in select settings and may be used outside of current evidence-based recommendations in real-world practice. Methods A institutional FDG-PET/CT database of scans performed between 2000 and 2020 for adults...
An Efficient Solvent-free Synthesis of Spiro-substituted Cyclopropanes by Grinding
Changqing Wang & Liu Yang
An Efficient Solvent-free Synthesis of Spiro-substituted Cyclopropanes by Grinding
An Efficient Solvent-free Synthesis of Spiro-substituted Cyclopropanes by Grinding
Changqing Wang & Liu Yang
An Efficient Solvent-free Synthesis of Spiro-substituted Cyclopropanes by Grinding
Long non-coding RNA MCM3AP antisense RNA 1 silencing upregulates microRNA-24-3p to accelerate proliferation and migration of vascular endothelial cells in myocardial infarction rats by reducing EIF4G2
Ke Chen, Min Xi, Qihong Huang, Hao Wu, Guirong Lu, Shaohui Song & Wei Shi
Long non-coding RNAs (lncRNAs) are crucial drivers in the progression of human diseases such as myocardial infarction (MI). However, the impact of lncRNA MCM3AP antisense RNA 1 (MCM3AP-AS1) on MI remains unknown. This research was determined to explore the effect of MCM3AP-AS1 modulating microRNA-24-3p (miR-24-3p) and eukaryotic translation initiation factor 4 gamma 2 (EIF4G2) on MI. The rat MI models were constructed and, respectively, treated with altered MCM3AP-AS1, miR-24-3p or/and EIF4G2. Subsequently, the cardiac function,...
Long non-coding RNA MCM3AP antisense RNA 1 silencing upregulates microRNA-24-3p to accelerate proliferation and migration of vascular endothelial cells in myocardial infarction rats by reducing EIF4G2
Ke Chen, Min Xi, Qihong Huang, Hao Wu, Guirong Lu, Shaohui Song & Wei Shi
Long non-coding RNAs (lncRNAs) are crucial drivers in the progression of human diseases such as myocardial infarction (MI). However, the impact of lncRNA MCM3AP antisense RNA 1 (MCM3AP-AS1) on MI remains unknown. This research was determined to explore the effect of MCM3AP-AS1 modulating microRNA-24-3p (miR-24-3p) and eukaryotic translation initiation factor 4 gamma 2 (EIF4G2) on MI. The rat MI models were constructed and, respectively, treated with altered MCM3AP-AS1, miR-24-3p or/and EIF4G2. Subsequently, the cardiac function,...
Pharmacogenomics guided dosing for fluoropyrimidine and irinotecan chemotherapies for patients with cancer (PACIFIC-PGx): study protocol of a multicentre clinical trial
Sarah Glewis, Marliese Alexander, Senthil Lingaratnam, Benjamin Lee, Ian Campbell, Mei Krishnasamy, Maarten IJzerman, Mussab Fagery, Sam Harris, Chloe Georgiou, Craig Underhill, Mark Warren, Robert Campbell, Jennifer Martin, Jeanne Tie & Michael Michael
Pharmacogenomics guided dosing for fluoropyrimidine and irinotecan chemotherapies for patients with cancer (PACIFIC-PGx): study protocol of a multicentre clinical trial
Pharmacogenomics guided dosing for fluoropyrimidine and irinotecan chemotherapies for patients with cancer (PACIFIC-PGx): study protocol of a multicentre clinical trial
Sarah Glewis, Marliese Alexander, Senthil Lingaratnam, Benjamin Lee, Ian Campbell, Mei Krishnasamy, Maarten IJzerman, Mussab Fagery, Sam Harris, Chloe Georgiou, Craig Underhill, Mark Warren, Robert Campbell, Jennifer Martin, Jeanne Tie & Michael Michael
Pharmacogenomics guided dosing for fluoropyrimidine and irinotecan chemotherapies for patients with cancer (PACIFIC-PGx): study protocol of a multicentre clinical trial
Real-world clinical outcomes and cost estimates of metastatic castration-resistant prostate cancer treatment: does sequencing of taxanes and androgen receptor-targeted agents matter?
Amanda Pereira-Salgado, Angelyn Anton, Fanny Franchini, Robert K. Mahar, Edmond M. Kwan, Shirley Wong, Julia Shapiro, Andrew Weickhardt, Arun A. Azad, Lavinia Spain, Ashray Gunjur, Javier Torres, Phillip Parente, Francis Parnis, Jeffrey Goh, Christopher Steer, Stephen Brown, Peter Gibbs, Ben Tran & Maarten IJzerman
Health economic outcomes of real-world treatment sequencing of androgen receptor-targeted agents (ARTA) and docetaxel (DOC) remain unclear. Data from the electronic Castration-resistant Prostate cancer Australian Database (ePAD) were analyzed including median overall survival (mOS) and median time-to-treatment failure (mTTF). Mean total costs (mTC) and incremental cost-effectiveness ratios (ICER) of treatment sequences were estimated using the average sample method and Zhao and Tian estimator. Of 752 men, 441 received ARTA, 194 DOC, and 175 both sequentially....
JAK1 inactivation promotes proliferation and migration of endometrial cancer cells via upregulating the hypoxia-inducible factor signaling pathway
Qin Lin, Zheng Chen, Wei Shi, Zeheng Lv, Xiaoping Wan & Kun Gao
Abstract Background Loss-of-function (LOF) mutations of JAK1, a member of the JAK kinase family, were frequently observed in EC, indicating that JAK1 may act as a tumor suppressor, at least in EC. However, the mechanism of JAK1 mediated regulation of tumorigenesis remains poorly understood. Methods The genetic alterations of JAK1 in EC using latest sequencing dataset of EC deposited in TCGA database. The RNA-Seq dataset of EC and normal endometrial tissues from TCGA cohort was...
Additional file 2 of Ganciclovir-induced mutations are present in a diverse spectrum of post-transplant malignancies
Hu Fang, Helen H. N. Yan, Rebecca A. Bilardi, Christoffer Flensburg, Haocheng Yang, Jayne A. Barbour, Hoi Cheong Siu, Michelle Turski, Edward Chew, Zhen Xu, Siu T. Lam, Rakesh Sharma, Mengya Xu, Junshi Li, Ho W. Ip, Carol Y. M. Cheung, Michael S. Y. Huen, E. Alejandro Sweet-Cordero, Ian J. Majewski, Suet Y. Leung & Jason W. H. Wong
Additional file 2. Supplementary Methods.
Ganciclovir-induced mutations are present in a diverse spectrum of post-transplant malignancies
Hu Fang, Helen H. N. Yan, Rebecca A. Bilardi, Christoffer Flensburg, Haocheng Yang, Jayne A. Barbour, Hoi Cheong Siu, Michelle Turski, Edward Chew, Zhen Xu, Siu T. Lam, Rakesh Sharma, Mengya Xu, Junshi Li, Ho W. Ip, Carol Y. M. Cheung, Michael S. Y. Huen, E. Alejandro Sweet-Cordero, Ian J. Majewski, Suet Y. Leung & Jason W. H. Wong
Abstract Background Ganciclovir (GCV) is widely used in solid organ and haematopoietic stem cell transplant patients for prophylaxis and treatment of cytomegalovirus. It has long been considered a mutagen and carcinogen. However, the contribution of GCV to cancer incidence and other factors that influence its mutagenicity remains unknown. Methods This retrospective cohort study analysed genomics data for 121,771 patients who had undergone targeted sequencing compiled by the Genomics Evidence Neoplasia Information Exchange (GENIE) or Foundation...
Ganciclovir-induced mutations are present in a diverse spectrum of post-transplant malignancies
Hu Fang, Helen H. N. Yan, Rebecca A. Bilardi, Christoffer Flensburg, Haocheng Yang, Jayne A. Barbour, Hoi Cheong Siu, Michelle Turski, Edward Chew, Zhen Xu, Siu T. Lam, Rakesh Sharma, Mengya Xu, Junshi Li, Ho W. Ip, Carol Y. M. Cheung, Michael S. Y. Huen, E. Alejandro Sweet-Cordero, Ian J. Majewski, Suet Y. Leung & Jason W. H. Wong
Abstract Background Ganciclovir (GCV) is widely used in solid organ and haematopoietic stem cell transplant patients for prophylaxis and treatment of cytomegalovirus. It has long been considered a mutagen and carcinogen. However, the contribution of GCV to cancer incidence and other factors that influence its mutagenicity remains unknown. Methods This retrospective cohort study analysed genomics data for 121,771 patients who had undergone targeted sequencing compiled by the Genomics Evidence Neoplasia Information Exchange (GENIE) or Foundation...
sj-docx-1-jom-10.1177_01492063221126707 - Supplemental material for How Shareholders Impact Stakeholder Interests: A Review and Map for Future Research
Mark R. DesJardine, Muhan Zhang & Wei Shi
Supplemental material, sj-docx-1-jom-10.1177_01492063221126707 for How Shareholders Impact Stakeholder Interests: A Review and Map for Future Research by Mark R. DesJardine, Muhan Zhang, and Wei Shi in Journal of Management
sj-docx-1-jom-10.1177_01492063221126707 - Supplemental material for How Shareholders Impact Stakeholder Interests: A Review and Map for Future Research
Mark R. DesJardine, Muhan Zhang & Wei Shi
Supplemental material, sj-docx-1-jom-10.1177_01492063221126707 for How Shareholders Impact Stakeholder Interests: A Review and Map for Future Research by Mark R. DesJardine, Muhan Zhang, and Wei Shi in Journal of Management
Low STING expression promotes endometrial stromal cell invasion and migration via the STING/IRF-3/IFN-β1 pathway in eutopic endometrium of women with endometriosis
Zhen Xu, Heng Zhao, Caixin Yue, Lixia Zhang, Muzi Li, Yanbo Du, Na Zhang & Lei Yan
Aims: The primary aim of the current study was to elucidate the function of the stimulator of interferon genes (STING) in the eutopic endometrium of women with endometriosis. Materials and Methods: STING expression and signaling pathways were verified by western blot analysis and immunohistochemistry after si-STING treatment. Cell proliferation and invasion and migration were assessed using 5-ethynyl-2’-deoxyuridine and transwell assays, respectively. Results: Within endometriosis tissues, STING was primarily expressed in the stroma of the eutopic...
Low STING expression promotes endometrial stromal cell invasion and migration via the STING/IRF-3/IFN-β1 pathway in eutopic endometrium of women with endometriosis
Zhen Xu, Heng Zhao, Caixin Yue, Lixia Zhang, Muzi Li, Yanbo Du, Na Zhang & Lei Yan
Aims: The primary aim of the current study was to elucidate the function of the stimulator of interferon genes (STING) in the eutopic endometrium of women with endometriosis. Materials and Methods: STING expression and signaling pathways were verified by western blot analysis and immunohistochemistry after si-STING treatment. Cell proliferation and invasion and migration were assessed using 5-ethynyl-2’-deoxyuridine and transwell assays, respectively. Results: Within endometriosis tissues, STING was primarily expressed in the stroma of the eutopic...
Real-world clinical outcomes and cost estimates of metastatic castration-resistant prostate cancer treatment: does sequencing of taxanes and androgen receptor-targeted agents matter?
Amanda Pereira-Salgado, Angelyn Anton, Fanny Franchini, Robert K. Mahar, Edmond M. Kwan, Shirley Wong, Julia Shapiro, Andrew Weickhardt, Arun A. Azad, Lavinia Spain, Ashray Gunjur, Javier Torres, Phillip Parente, Francis Parnis, Jeffrey Goh, Christopher Steer, Stephen Brown, Peter Gibbs, Ben Tran & Maarten IJzerman
Health economic outcomes of real-world treatment sequencing of androgen receptor-targeted agents (ARTA) and docetaxel (DOC) remain unclear. Data from the electronic Castration-resistant Prostate cancer Australian Database (ePAD) were analyzed including median overall survival (mOS) and median time-to-treatment failure (mTTF). Mean total costs (mTC) and incremental cost-effectiveness ratios (ICER) of treatment sequences were estimated using the average sample method and Zhao and Tian estimator. Of 752 men, 441 received ARTA, 194 DOC, and 175 both sequentially....
Additional file 2 of JAK1 inactivation promotes proliferation and migration of endometrial cancer cells via upregulating the hypoxia-inducible factor signaling pathway
Qin Lin, Zheng Chen, Wei Shi, Zeheng Lv, Xiaoping Wan & Kun Gao
Additional file 2: Fig. S1. JAK1 overexpression suppresses EC cell growth and migration.
Additional file 3 of JAK1 inactivation promotes proliferation and migration of endometrial cancer cells via upregulating the hypoxia-inducible factor signaling pathway
Qin Lin, Zheng Chen, Wei Shi, Zeheng Lv, Xiaoping Wan & Kun Gao
Additional file 3: Fig. S2. JAK1 knockdown elevates the expression of HIF downstream genes in SPEC-2 cells.
Additional file 4 of JAK1 inactivation promotes proliferation and migration of endometrial cancer cells via upregulating the hypoxia-inducible factor signaling pathway
Qin Lin, Zheng Chen, Wei Shi, Zeheng Lv, Xiaoping Wan & Kun Gao
Additional file 4: Fig. S3. JAK1 overexpression downregulates the expression of HIF downstream genes in Ishikawa cells.
Additional file 1 of Ganciclovir-induced mutations are present in a diverse spectrum of post-transplant malignancies
Hu Fang, Helen H. N. Yan, Rebecca A. Bilardi, Christoffer Flensburg, Haocheng Yang, Jayne A. Barbour, Hoi Cheong Siu, Michelle Turski, Edward Chew, Zhen Xu, Siu T. Lam, Rakesh Sharma, Mengya Xu, Junshi Li, Ho W. Ip, Carol Y. M. Cheung, Michael S. Y. Huen, E. Alejandro Sweet-Cordero, Ian J. Majewski, Suet Y. Leung & Jason W. H. Wong
Additional file 1: Table S1. Clinical and mutational information of patients with GCVsig identified in this study and from our previous patients. Table S2. Patient and panel characteristics of GENIE and FM cohorts. Table S3. Concentrations used for the treatment of respective cell lines for WGS mutation experiments. Table S4. Cosine similarity of COSMICv3 signatures with GCVsig. Table S5. GENIE and FM samples analysed in the study with their trinucleotide mutational signature and similarity to...
Affiliations
-
Walter and Eliza Hall Institute of Medical Research40
-
University of Melbourne37
-
West China Hospital of Sichuan University18
-
Huazhong University of Science and Technology18
-
ShenZhen People’s Hospital18
-
La Trobe University18
-
Guangdong Academy of Medical Sciences18
-
China Earthquake Administration18
-
Olivia Newton-John Cancer Wellness & Research Centre18
-
Affiliated Hospital of Shandong University of Traditional Chinese Medicine18